Research Progress on Pathophysiology, Prevention and Treatment of Restenosis after Percutaneous Coronary Intervention by Integrative Medicine
10.11842/wst.2015.02.003
- VernacularTitle:支架置入后再狭窄病生机制及其防治的中西医研究进展
- Author:
Chunying SI
;
He WANG
;
Minghua LUO
;
Jinhong XIE
;
Yushan CHEN
;
Huaimin GUAN
;
Xiaojun SHEN
- Publication Type:Journal Article
- Keywords:
Coronary heart disease;
interventional therapy;
restenosis;
integrative medicine
- From:
World Science and Technology-Modernization of Traditional Chinese Medicine
2015;(2):311-318
- CountryChina
- Language:Chinese
-
Abstract:
With the increasing incidence and mortality of coronary heart disease (CHD) in China, the prevention and treatment of CHD is no time to delay. Since Professor Gruentzig completed the first human case of percutaneous transluminal coronary angioplasty (PTCA) in 1977, percutaneous coronary intervention (PCI) had reached to a new page. After three decades of development and change, PCI has been improved and matured gradually from the early PTCA to the current stent era. With the advent of stents, the rate of restenosis after PCI was significantly reduced from 30%-50% to 10%-20%. But stent restenosis was still with no total cure. The issue of how to prevent the stent restenosis has become a long-term major issue for the exploration in both clinical and preclinical medicine. Therefore, this paper reviewed the etiology, pathology, related risk factors, latest diagnosis methods, prevention and treatment of stent restenosis by integrative medicine.
